PORTFOLIO NEWS Denali Therapeutics Reports Third Quarter 2019 Financial Results and Business Highlights Nov 6, 2019 Editas Medicine Appoints Judith R. Abrams, M.D., as CMO Oct 28, 2019 BlackThorn Therapeutics Reports New Insights into Neurobehavioral Disorders Oct 23, 2019 Compass Therapeutics Appoints Leading Immuno-Oncology Researchers to its Immuno-Oncology Scientific Advisory Board Oct 22, 2019 BlackThorn Therapeutics Appoints William J. Martin, Ph.D., as CEO to Lead New Stage Growth Oct 21, 2019 Editas Medicine and AskBio Enter Strategic Research Collaboration Oct 15, 2019 The American Academy of Ophthalmology and Verana Health Accelerate Clinical Trials for Patients with Rare, Sight-Threatening Retinal Diseases Oct 9, 2019 GRAIL Announces Positive Validation Data for its Multi-Cancer Early Detection Test Oct 7, 2019 GRAIL Appoints Matthew Young as Chief Operating Officer and Chief Financial Officer Oct 7, 2019 Editas Medicine and MaxCyte Announce Clinical and Commercial License Agreement Oct 7, 2019 « Older Entries Next Entries » PORTFOLIO PRESS COVERAGE Mission Matters: These 5 Companies are Creating Positive Change Mar 1, 2019 Verana Health Continues to Strengthen Leadership Team with Several Hires Feb 28, 2019 10 Health Tech Companies to Watch in 2019 Feb 10, 2019 Align Clinical CRO, ZappRx, SAP, And More: News From January 2019 Jan 30, 2019 Bloomberg Radio | Julie Sunderland, CEO at eGenesis, explains a gene editing platform for the development of human-compatible organs, tissues and cells Jan 9, 2019 High-performance Medicine: The Convergence of Human and Artificial Intelligence Jan 7, 2019 BioCentury: BayHelix launches Gene-Editing Task Force Dec 12, 2018 Multiple Sclerosis News Today: Denali and Sanofi Partner to Develop Potential Treatments for MS, Other Neurological Disorders Nov 6, 2018 Healthcare Dive: North Carolina proposes setting hospital payments for state employees on Medicare rates Nov 6, 2018 Fierce Healthcare: American Hospital Association plans to sue CMS over final site-neutral payment rule Nov 2, 2018 « Older Entries Next Entries »
Compass Therapeutics Appoints Leading Immuno-Oncology Researchers to its Immuno-Oncology Scientific Advisory Board Oct 22, 2019
BlackThorn Therapeutics Appoints William J. Martin, Ph.D., as CEO to Lead New Stage Growth Oct 21, 2019
The American Academy of Ophthalmology and Verana Health Accelerate Clinical Trials for Patients with Rare, Sight-Threatening Retinal Diseases Oct 9, 2019
Bloomberg Radio | Julie Sunderland, CEO at eGenesis, explains a gene editing platform for the development of human-compatible organs, tissues and cells Jan 9, 2019
Multiple Sclerosis News Today: Denali and Sanofi Partner to Develop Potential Treatments for MS, Other Neurological Disorders Nov 6, 2018
Healthcare Dive: North Carolina proposes setting hospital payments for state employees on Medicare rates Nov 6, 2018
Fierce Healthcare: American Hospital Association plans to sue CMS over final site-neutral payment rule Nov 2, 2018
